Netherton Syndrome: A Comprehensive Literature Review of Pathogenesis, Clinical Manifestations, and Therapeutic Strategies

1. Comèl M. Ichthyosis linearis circumflexa. Dermatology. 1949;98(3):133–6. ComèlM Ichthyosis linearis circumflexa Dermatology 1949 98 3 133 6 Search in Google Scholar

2. Netherton EW. A unique case of trichorrhexis nodosa—”bamboo hairs.” Arch Dermatol. 1958 Oct 1;78(4):483–7. doi: 10.1001/archderm.1958.01560100059009. NethertonEW A unique case of trichorrhexis nodosa—”bamboo hairs.” Arch Dermatol 1958 Oct 1 78 4 483 7 10.1001/archderm.1958.01560100059009 Open DOISearch in Google Scholar

3. Sun JD, Linden KG. Netherton syndrome: a case report and review of the literature. Int J Dermatol. 2006 Jun 20;45(6):693–7. doi: 10.1111/j.1365-4632.2005.02637.x. SunJD LindenKG Netherton syndrome: a case report and review of the literature Int J Dermatol 2006 Jun 20 45 6 693 7 10.1111/j.1365-4632.2005.02637.x Open DOISearch in Google Scholar

4. Sarri CA, Roussaki-Schulze A, Vasilopoulos Y, Zafiriou E, Patsatsi A, Stamatis C, et al. Netherton syndrome: A genotype-phenotype review. Mol Diagn Ther. 2017 Apr 30;21(2):137–52. doi: 10.1007/s40291-016-0243-y. SarriCA Roussaki-SchulzeA VasilopoulosY ZafiriouE PatsatsiA StamatisC Netherton syndrome: A genotype-phenotype review Mol Diagn Ther 2017 Apr 30 21 2 137 52 10.1007/s40291-016-0243-y Open DOISearch in Google Scholar

5. Barbati F, Giovannini M, Oranges T, Lodi L, Barni S, Novembre E, et al. Netherton syndrome in children: management and future perspectives. Front Pediatr. 2021;9:645259. doi: 10.3389/fped.2021.645259. BarbatiF GiovanniniM OrangesT LodiL BarniS NovembreE Netherton syndrome in children: management and future perspectives Front Pediatr 2021 9 645259 10.3389/fped.2021.645259 Open DOISearch in Google Scholar

6. Herz-Ruelas ME, Chavez-Alvarez S, Garza-Chapa JI, Ocampo-Candiani J, Cab-Morales VA, Kubelis-López DE. Netherton syndrome: case report and review of the literature. Skin Appendage Disord. 2021 Aug;7(5):346–50. doi: 10.1159/000514699. Herz-RuelasME Chavez-AlvarezS Garza-ChapaJI Ocampo-CandianiJ Cab-MoralesVA Kubelis-LópezDE Netherton syndrome: case report and review of the literature Skin Appendage Disord 2021 Aug 7 5 346 50 10.1159/000514699 Open DOISearch in Google Scholar

7. Sprecher E, Amin S, Nielsen K, Pfendner E, Uitto J, Richard G, et al. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: Implications for mutation detection and first case of prenatal diagnosis. J. Invest. Dermatol. 2001 Aug;117(2):179–87. doi: 10.1046/j.1523-1747.2001.01389.x. SprecherE AminS NielsenK PfendnerE UittoJ RichardG The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: Implications for mutation detection and first case of prenatal diagnosis J. Invest. Dermatol. 2001 Aug 117 2 179 87 10.1046/j.1523-1747.2001.01389.x Open DOISearch in Google Scholar

8. Pontone M, Giovannini M, Filippeschi C, Oranges T, Pedaci FA, Mori F, et al. Biological treatments for pediatric Netherton syndrome. Front Pediatr. 2022 Dec 23;10:1074243. doi: 10.3389/fped.2022.1074243. PontoneM GiovanniniM FilippeschiC OrangesT PedaciFA MoriF Biological treatments for pediatric Netherton syndrome Front Pediatr 2022 Dec 23 10 1074243 10.3389/fped.2022.1074243 Open DOISearch in Google Scholar

9. Kostova P, Petrova G, Shahid M, Papochieva V, Miteva D, Yordanova I, et al. Netherton syndrome – A therapeutic challenge in childhood. Clin Case Rep. 2024 Apr 16;12(4):e8770. doi: 10.1002/ccr3.8770. KostovaP PetrovaG ShahidM PapochievaV MitevaD YordanovaI Netherton syndrome – A therapeutic challenge in childhood Clin Case Rep 2024 Apr 16 12 4 e8770 10.1002/ccr3.8770 Open DOISearch in Google Scholar

10. Stuvel K, Heeringa JJ, Dalm VASH, Meijers RWJ, van Hoffen E, Gerritsen SAM, et al. Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency. Allergy. 2020 Jul 21;75(7):1710–20. doi: 10.1111/all.14197. StuvelK HeeringaJJ DalmVASH MeijersRWJ van HoffenE GerritsenSAM Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency Allergy 2020 Jul 21 75 7 1710 20 10.1111/all.14197 Open DOISearch in Google Scholar

11. SPINK5. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. https://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPINK5. 2025. SPINK5 The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff https://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPINK5. 2025 Search in Google Scholar

12. Xu M, Shi Y, Lin L, Wang L, Zhu X, Xiong J, et al. The role of SPINK5 mutation distribution in phenotypes of Netherton syndrome. Front Genet. 2025 Jan 27;16:1475054. doi: 10.3389/fgene.2025.1475054. XuM ShiY LinL WangL ZhuX XiongJ The role of SPINK5 mutation distribution in phenotypes of Netherton syndrome Front Genet 2025 Jan 27 16 1475054 10.3389/fgene.2025.1475054 Open DOISearch in Google Scholar

13. Barbieux C, Bonnet des Claustres M, Fahrner M, Petrova E, Tsoi LC, Gouin O, et al. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses. J. Allergy Clin. Immunol. 2022 Apr;149(4):1358–72. doi: 10.1016/j.jaci.2021.08.024. BarbieuxC Bonnet des ClaustresM FahrnerM PetrovaE TsoiLC GouinO Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses J. Allergy Clin. Immunol. 2022 Apr 149 4 1358 72 10.1016/j.jaci.2021.08.024 Open DOISearch in Google Scholar

14. Błażewicz I, Rustowska A, Wilkowska A, Nowicki RJ. Comèl-Netherton syndrome – case report. Przegl Dermatol. 2014;101:481–6. doi: 10.5114/dr.2014.46950 BłażewiczI RustowskaA WilkowskaA NowickiRJ Comèl-Netherton syndrome – case report Przegl Dermatol 2014 101 481 6 10.5114/dr.2014.46950 Open DOISearch in Google Scholar

15. Smith DL, Smith JG, Wong SW, deShazo RD. Netherton’s syndrome: A syndrome of elevated IgE and characteristic skin and hair findings. J. Allergy Clin. Immunol. 1995 Jan;95(1):116–23. doi: 10.1016/S0091-6749(95)70159-1 SmithDL SmithJG WongSW deShazoRD Netherton’s syndrome: A syndrome of elevated IgE and characteristic skin and hair findings J. Allergy Clin. Immunol. 1995 Jan 95 1 116 23 10.1016/S0091-6749(95)70159-1 Open DOISearch in Google Scholar

16. Bittencourt M de JS, Moure ERD, Pies OTC, Mendes AD, Deprá MM, Mello ALP de. Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome. An Bras Dermatol. 2015 Feb;90(1):114–6. doi: 10.1590/abd1806-4841.20153011 BittencourtM de JS MoureERD PiesOTC MendesAD DepráMM MelloALP de Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome An Bras Dermatol 2015 Feb 90 1 114 6 10.1590/abd1806-4841.20153011 Open DOISearch in Google Scholar

17. Geyer AS, Ratajczak P, Pol-Rodriguez M, Millar WS, Garzon M, Richard G. Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5. Dermatology. 2005;210(4):308–14. doi: 10.1159/000084755. GeyerAS RatajczakP Pol-RodriguezM MillarWS GarzonM RichardG Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5 Dermatology 2005 210 4 308 14 10.1159/000084755 Open DOISearch in Google Scholar

18. Mazereeuw-Hautier J, Paller AS, O’Toole E, Dreyfus I, Bodemer C, Akiyama M, et al. Management of congenital ichthyoses: guidelines of care: Part two: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):28–43. doi: 10.1093/bjd/ljaf077. Mazereeuw-HautierJ PallerAS O’TooleE DreyfusI BodemerC AkiyamaM Management of congenital ichthyoses: guidelines of care: Part two: 2024 update Br J Dermatol 2025 Jun 20 193 1 28 43 10.1093/bjd/ljaf077 Open DOISearch in Google Scholar

19. Lucker GP, van de Kerkhof PC, van Dïjk MR, Steijlen PM. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol. 1994 Oct;131(4):546–50. doi: 10.1111/j.1365-2133.1994.tb08558.x. LuckerGP van de KerkhofPC van DïjkMR SteijlenPM Effect of topical calcipotriol on congenital ichthyoses Br J Dermatol 1994 Oct 131 4 546 50 10.1111/j.1365-2133.1994.tb08558.x Open DOISearch in Google Scholar

20. Luchsinger I, Knöpfel N, Theiler M, Bonnet des Claustres M, Barbieux C, Schwieger-Briel A, et al. Secukinumab therapy for Netherton syndrome. JAMA Dermatol. 2020 Aug 1;156(8):907–11. doi: 10.1001/jamadermatol.2020.1019 LuchsingerI KnöpfelN TheilerM Bonnet des ClaustresM BarbieuxC Schwieger-BrielA Secukinumab therapy for Netherton syndrome JAMA Dermatol 2020 Aug 1 156 8 907 11 10.1001/jamadermatol.2020.1019 Open DOISearch in Google Scholar

21. Volc S, Maier L, Gritsch A, Aichelburg MC, Volc-Platzer B. Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl. British Journal of Dermatology. 2020 Jul 9;183(1):165–7. doi: 10.1111/bjd.18892. VolcS MaierL GritschA AichelburgMC Volc-PlatzerB Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl British Journal of Dermatology 2020 Jul 9 183 1 165 7 10.1111/bjd.18892 Open DOISearch in Google Scholar

22. Yalcin AD. A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels. Immunopharmacol Immunotoxicol. 2016 Mar 3;38(2):162–6. doi: 10.3109/08923973.2015.1115518. YalcinAD A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels Immunopharmacol Immunotoxicol 2016 Mar 3 38 2 162 6 10.3109/08923973.2015.1115518 Open DOISearch in Google Scholar

23. Süßmuth K, Traupe H, Loser K, Ständer S, Kessel C, Wittkowski H, et al. Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e152–5. doi: 10.1111/jdv.16883. SüßmuthK TraupeH LoserK StänderS KesselC WittkowskiH Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling J Eur Acad Dermatol Venereol 2021 Feb 35 2 e152 5 10.1111/jdv.16883 Open DOISearch in Google Scholar

24. Murase C, Takeichi T, Taki T, Yoshikawa T, Suzuki A, Ogi T, et al. Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome. J Dermatol Sci. 2021 May;102(2):126–9. doi: 10.1016/j.jdermsci.2021.03.003. MuraseC TakeichiT TakiT YoshikawaT SuzukiA OgiT Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome J Dermatol Sci 2021 May 102 2 126 9 10.1016/j.jdermsci.2021.03.003 Open DOISearch in Google Scholar

25. Andreasen TH, Karstensen HG, Duno M, Lei U, Zachariae C, Thyssen JP. Successful treatment with dupilumab of an adult with Netherton syndrome. Clin Exp Dermatol. 2020 Oct;45(7):915–7. doi: 10.1111/ced.14317. AndreasenTH KarstensenHG DunoM LeiU ZachariaeC ThyssenJP Successful treatment with dupilumab of an adult with Netherton syndrome Clin Exp Dermatol 2020 Oct 45 7 915 7 10.1111/ced.14317 Open DOISearch in Google Scholar

26. Mazereeuw-Hautier J, Paller AS, Dreyfus I, Sprecher E, O’Toole E, Bodemer C, et al. Management of congenital ichthyoses: Guidelines of care: Part one: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):16–27. doi: 10.1093/bjd/ljaf076. Mazereeuw-HautierJ PallerAS DreyfusI SprecherE O’TooleE BodemerC Management of congenital ichthyoses: Guidelines of care: Part one: 2024 update Br J Dermatol 2025 Jun 20 193 1 16 27 10.1093/bjd/ljaf076 Open DOISearch in Google Scholar

27. Liddle J, Beneton V, Benson M, Bingham R, Bouillot A, Boullay AB, et al. A potent and selective kallikrein-5 inhibitor delivers high pharmacological activity in skin from patients with Netherton syndrome. J Invest Dermatol. 2021 Sep;141(9):2272–9. doi: 10.1016/j.jid.2021.01.029 LiddleJ BenetonV BensonM BinghamR BouillotA BoullayAB A potent and selective kallikrein-5 inhibitor delivers high pharmacological activity in skin from patients with Netherton syndrome J Invest Dermatol 2021 Sep 141 9 2272 9 10.1016/j.jid.2021.01.029 Open DOISearch in Google Scholar

28. Zingkou E, Pampalakis G, Sotiropoulou G. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome. Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165831. doi: 10.1016/j.bbadis.2020.165831. ZingkouE PampalakisG SotiropoulouG Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome Biochim Biophys Acta Mol Basis Dis 2020 Oct 1 1866 10 165831 10.1016/j.bbadis.2020.165831 Open DOISearch in Google Scholar

29. Di WL, Lwin SM, Petrova A, Bernadis C, Syed F, Farzaneh F, et al. Generation and clinical application of gene-modified autologous epidermal sheets in Netherton syndrome: Lessons learned from a Phase 1 trial. Hum Gene Ther. 2019 Sep 1;30(9):1067–78. doi: 10.1089/hum.2019.049 DiWL LwinSM PetrovaA BernadisC SyedF FarzanehF Generation and clinical application of gene-modified autologous epidermal sheets in Netherton syndrome: Lessons learned from a Phase 1 trial Hum Gene Ther 2019 Sep 1 30 9 1067 78 10.1089/hum.2019.049 Open DOISearch in Google Scholar

30. Salehi M, Neshati Z, Ahanchian H, Tafrishi R, Pasdar A, Safi M, et al. Hyper IgE syndromes: understanding, management, and future perspectives: a narrative review. Health Sci Rep. 2025 Mar 19;8(3). doi: 10.1002/hsr2.70497 SalehiM NeshatiZ AhanchianH TafrishiR PasdarA SafiM Hyper IgE syndromes: understanding, management, and future perspectives: a narrative review Health Sci Rep 2025 Mar 19 8 3 10.1002/hsr2.70497 Open DOISearch in Google Scholar